Business Context and Reporting Period
Company: Klotho Neurosciences, Inc. (formerly ANEW Medical, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2025
Business Overview: The Company is a pre-revenue biopharmaceutical entity developing essential medicines for chronic diseases, including cancer, cardiovascular, and neurodegenerative disorders. It operates via a generic drug portfolio, a biosimilar biologics platform, and a proprietary gene therapy platform targeting the "Klotho" protein. The Company completed a reverse merger with Redwoods Acquisition Corp. in June 2024.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Revenue | $0 | $0 |
| Net Loss | $(2,233,982) | $(672,044) |
| Net Loss Per Share (Basic & Diluted) | $(0.08) | $(0.04) |
| Total Operating Expenses | $1,586,968 | $672,045 |
| Cash and Cash Equivalents (End of Period) | $565,869 | $32,336 |
| Net Cash Used in Operating Activities | $(1,553,747) | $(21,976) |
| Net Cash Provided by Financing Activities | $2,055,875 | $175,000 |
| Total Assets | $2,987,266 | $2,457,365 |
| Total Liabilities | $2,348,557 | $1,272,020 |
| Stockholders' Equity | $638,709 | $1,185,345 |
Debt and Liquidity: As of March 31, 2025, the Company held approximately $566,000 in cash. Total current liabilities were $2,337,586, driven primarily by notes payable ($1,767,920) and accrued expenses ($481,016). The Company has an accumulated deficit of approximately $12.8 million.
Material Changes vs. Prior Period
- Net Loss Expansion: Net loss increased by approximately $1.56 million (232% increase) compared to Q1 2024. This was driven by a $914,923 increase in operating expenses and significant non-operating costs.
- Operating Expenses: Total operating expenses rose from $672,045 to $1,586,968. Key drivers included:
- Professional Fees: Increased from $375,596 to $736,686.
- General and Administrative: Increased from $9,198 to $354,782.
- Share-Based Compensation: Increased from $287,251 to $495,500.
- Non-Operating Items: Q1 2025 included $553,937 in interest expense and a $117,256 loss on debt conversion, neither of which were present in Q1 2024.
- Debt Structure: The Company entered into new convertible promissory notes (including a $2.0 million agreement with 3i LP and notes with Austria Capital and Red Road Holdings) and converted existing debt into equity during the quarter.
Outlook, Risks, and Management Commentary
- Going Concern: Management has expressed substantial doubt about the Company's ability to continue as a going concern for twelve months from the filing date. The Company relies on additional equity or debt financing to fund operations and development plans.
- NASDAQ Compliance: The Company received notices of non-compliance with Nasdaq Listing Rules regarding minimum bid price ($1.00) and market value of publicly held shares. The Nasdaq Listing Qualifications Panel granted a request to continue listing subject to the completion of the acquisition of SB Security Holdings, LLC by August 13, 2025.
- Acquisition Activity: On March 26, 2025, the Company entered into a Share Exchange Agreement to acquire SB Security Holdings, LLC (a video doorbell service company) in exchange for 90% of the Company's fully-diluted shares. This transaction is subject to shareholder and Nasdaq approval.
- Internal Controls: Management concluded that internal controls over financial reporting were ineffective as of March 31, 2025, citing inadequate accounting resources and a lack of segregation of duties due to the small size of the accounting staff.
- Capitalization: The Company issued 1,429,717 shares of common stock in Q1 2025 to settle convertible notes and interest. Subsequent to the period end, further conversions and debt issuances occurred.
Investor Verification Checklist
- Going Concern Status: Verify the Company's ability to secure additional funding given the substantial doubt expressed in the filing and the negative operating cash flow of $1.55 million.
- NASDAQ Delisting Risk: Monitor the status of the SB Security Holdings acquisition and the Company's compliance with Nasdaq bid price and market value requirements by the August 13, 2025 deadline.
- Dilution Impact: Assess the impact of the proposed acquisition of SB Security Holdings, which involves issuing shares equal to 90% of the current outstanding shares, and the ongoing conversion of debt to equity.
- Debt Obligations: Review the terms of the new convertible notes (3i LP, Austria Capital, Red Road Holdings), including interest rates, conversion prices ($0.25/share), and maturity dates.
- Internal Control Weaknesses: Evaluate the risks associated with the identified material weaknesses in internal controls over financial reporting.